Major players of the Hungarian pharmaceutical scene are to hold discussions on government measures that have reportedly sent their businesses plummeting.
Key players of the pharmaceutical industry have been trying to arrange a discussion with the ministries concerned on the implementation of the medicine efficiency law. Today the ministers of the financial, economic and healthcare department are to take part in the discussion. Several leaders of pharmaceutical companies expressed concerns about the processes caused by the new law. György Leitner of GlaxoSmithKline (GSK) said the restrictive measures resulted in an 11% percent drop in turnover causing them to lay off 40 people and curb investments. He called the four annual price corrections as against innovation. The mostly foreign owned pharmaceutical firms may be forced to decrease their investments as profit forecasts are getting grim. (Napi Gazdaság)
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.